The DOI matches its Crossref record; 27 of the 27 references it cites were found in a registry or an index.
Clusterin inhibits apoptosis by interacting with activated Bax
Abstract
Clusterin is an enigmatic glycoprotein that is overexpressed in several human cancers such as prostate and breast cancers, and squamous cell carcinoma. Because the suppression of clusterin expression renders human cancer cells sensitive to chemotherapeutic drug-mediated apoptosis, it is currently an antisense target in clinical trials for prostate cancer. However, the molecular mechanisms by which clusterin inhibits apoptosis in human cancer cells are unknown. Here we report that intracellular clusterin inhibits apoptosis by interfering with Bax activation in mitochondria. Intriguingly, in contrast to other inhibitors of Bax, clusterin specifically interacts with conformation-altered Bax in response to chemotherapeutic drugs. This interaction impedes Bax oligomerization, which leads to the release of cytochrome c from mitochondria and caspase activation. Moreover, we also find that clusterin inhibits oncogenic c-Myc-mediated apoptosis by interacting with conformation-altered Bax. Clusterin promotes c-Myc-mediated transformation in vitro and tumour progression in vivo. Taken together, our results suggest that the elevated level of clusterin in human cancers may promote oncogenic transformation and tumour progression by interfering with Bax pro-apoptotic activities.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“CLU gene encodes clusterin or APOJ that besides its functions in lipid transport, membrane recycling, cell adhesion, and apoptosis (90, 444, 600, 677) affects transvascular A 𝛃 clearance by promoting A 𝛃 42 efflux across the BBB (580).”
From Blood-Brain Barrier: From Physiology to Disease and Back (2019) · cites this paper as [677]
Citations
Cites
1 retracted
Ku70 suppresses the apoptotic translocation of Bax to mitochondria
Sawada, M., Sun, W., Hayes, P. L., Leskov, K., Boothman, D. A., & Matsuyama, S. (2003) · Nature Cell Biology · doi:10.1038/ncb950 · Cited by 353
RetractedCleavage of BID by Caspase 8 Mediates the Mitochondrial Damage in the Fas Pathway of Apoptosis
Li, H., Zhu, H., Xu, C.-J., & Yuan, J. (1998) · Cell · doi:10.1016/s0092-8674(00)81590-1 · Cited by 4,445
Proapoptotic BAX and BAK: A Requisite Gateway to Mitochondrial Dysfunction and Death
Wei, M. C., Zong, W.-X., Cheng, E. H.-Y., Lindsten, T., Panoutsakopoulou, V., Ross, A. J., Roth, K. A., MacGregor, G. R., Thompson, C. B., & Korsmeyer, S. J. (2001) · Science · doi:10.1126/science.1059108 · Cited by 3,988
Bcl-2 gene promotes haemopoietic cell survival and cooperates with c-myc to immortalize pre-B cells
Vaux, D., Cory, S., & Adams, J. (1988) · Nature · doi:10.1038/335440a0 · Cited by 3,355
(2001) · PubMed · Cited by 2,381
Cheng, E. H. Y., Wei, M. C., Weiler, S., Flavell, R. A., Mak, T. W., Lindsten, T., & Korsmeyer, S. J. (2001) · Molecular Cell · doi:10.1016/s1097-2765(01)00320-3 · Cited by 1,735
Bid, Bax, and Lipids Cooperate to Form Supramolecular Openings in the Outer Mitochondrial Membrane
Kuwana, T., Mackey, M. R., Perkins, G. A., Ellisman, M. H., Latterich, M., Schneiter, R., Green, D. R., & Newmeyer, D. D. (2002) · Cell · doi:10.1016/s0092-8674(02)01036-x · Cited by 1,513
Wang, S., Gao, J., Lei, Q., Rozengurt, N., Pritchard, C., Jiao, J., Thomas, G. V., Li, G., Roy-Burman, P., Nelson, P. S., et al. (2003) · Cancer Cell · doi:10.1016/s1535-6108(03)00215-0 · Cited by 1,109
Apoptotic cell death induced by c-myc is inhibited by bcl-2
Bissonnette, R. P., Echeverri, F., Mahboubi, A., & Green, D. R. (1992) · Nature · doi:10.1038/359552a0 · Cited by 957
Zong, W., Lindsten, T., Ross, A. J., MacGregor, G. R., & Thompson, C. B. (2001) · Genes & Development · doi:10.1101/gad.897601 · Cited by 809
Flagged first, then by citations
Cited by
Sorted by citations
Items 301–400 of 451
Gulati, T., Huang, C., Caramia, F., Raghu, D., Paul, P. J., Goode, R. J. A., Keam, S. P., Williams, S., Haupt, S., Kleifeld, O., et al. (2018) · Molecular & Cellular Proteomics · doi:10.1074/mcp.ra117.000504 · Cited by 13
Insig2 is overexpressed in pancreatic cancer and its expression is induced by hypoxia
Kayashima, T., Nakata, K., Ohuchida, K., Ueda, J., Shirahane, K., Fujita, H., Cui, L., Mizumoto, K., & Tanaka, M. (2011) · Cancer Science · doi:10.1111/j.1349-7006.2011.01936.x · Cited by 13
Posttranscription Regulation of Prostate Cancer Growth
Shen, L., & Пили, Р. (2008) · The Cancer Journal · doi:10.1097/ppo.0b013e318162108a · Cited by 13
Tebbit, C. L., Zhai, J., Untch, B. R., Ellis, M. J., Dressman, H. K., Bentley, R. C., Baker, J. A., Marcom, P. K., Nevins, J. R., Marks, J. R., et al. (2009) · Breast Cancer Research and Treatment · doi:10.1007/s10549-008-0301-1 · Cited by 12
The Perspectives of Biomarkers in Predicting the Survival of the Renal Graft
Aldea, P. L., Răchişan, A. L., Stanciu, B. I., Picoș, A., Picoș, A., Delean, D. I., Stroescu, R. F., Stârcea, I. M., Borzan, C. M., & Elec, F. I. (2022) · Frontiers in Pediatrics · doi:10.3389/fped.2022.869628 · Cited by 13
Glycosylated clusterin species facilitate Aβ toxicity in human neurons
Foster, E. M., Fernandes, M., Dangla-Valls, A., Hublitz, P., Pangalos, M., Lovestone, S., Ribé, E. M., & Buckley, N. J. (2022) · Scientific Reports · doi:10.1038/s41598-022-23167-z · Cited by 12
Soldati, R., Wargon, V., Cerliani, J. P., Giulianelli, S., Vanzulli, S. I., Gorostiaga, M. A., Bolado, J., do Campo, P., Molinolo, A., Vollmer, G., et al. (2009) · Breast Cancer Research and Treatment · doi:10.1007/s10549-009-0659-8 · Cited by 12
Schwab, R., Caccamo, A. E., Bettuzzi, S., Anderson, J., & Sala, A. (2007) · Blood Cells Molecules and Diseases · doi:10.1016/j.bcmd.2007.04.006 · Cited by 12
Kim, H. H., Grande, S. M., Monroe, J. G., & Ross, S. R. (2012) · Journal of Virology · doi:10.1128/jvi.02029-12 · Cited by 12
Research in Castration-Resistant Rostate Cancer: What Does the Future Hold?
Macfarlane, R. J., & Chi, K. N. (2010) · Current Oncology · doi:10.3747/co.v17i0.702 · Cited by 12
Genistein Modulation of Immune-Associated Genes in LNCaP Prostate Cancer Cell Line
Merchant, K. (2012) · The Open Prostate Cancer Journal · doi:10.2174/1876822901205010001 · Cited by 12
19q13-ERCC1 Gene Copy Number Increase in Non–Small-Cell Lung Cancer
Vanhecke, E., Valent, A., Tang, X., Vielh, P. R., Friboulet, L., Tang, T., Goubar, A., Li, Y., Robin, A., Behrens, C., et al. (2013) · Clinical Lung Cancer · doi:10.1016/j.cllc.2013.01.006 · Cited by 12
Polimeno, L., Asabella, A. N., Mazzocca, A., Fazio, G. D., Polimeno, R., Buquicchio, R., Lavelli, V., & Rubini, G. (2018) · Journal of Clinical and Molecular Medicine · doi:10.15761/jcmm.1000102 · Cited by 11
Review of proteomics approach to eye diseases affecting the anterior segment
Aghamollaei, H., Parvin, S., & Shahriary, A. (2020) · Journal of Proteomics · doi:10.1016/j.jprot.2020.103881 · Cited by 11
Zhang, C., Zhang, X., Gong, Y., Li, T., Yang, L., Xu, W., & Dong, L. (2020) · Molecular Omics · doi:10.1039/d0mo00077a · Cited by 11
Choi, I., Kim, J., Park, J., & Kang, S. (2013) · Experimental Cell Research · doi:10.1016/j.yexcr.2013.01.025 · Cited by 11
Self-citationHotte, S. J. (2016) · Future Oncology · doi:10.2217/fon-2016-0279 · Cited by 11
Wang, D., Liang, H., Mao, X., Liu, W., Li, M., & Qiu, S. (2012) · Translational Oncology · doi:10.1593/tlo.11259 · Cited by 11
Oligomeric amyloid beta prevents myelination in a clusterin-dependent mannerPreprint
Beiter, R. M., Ennerfelt, H. E., Rivet-Noor, C. R., Merchak, A. R., Bai, R., Johanson, D. M., Slogar, E. R., Sol‐Church, K., Phillips, J. L., Bathe, T., et al. (2020) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2020.03.06.981373 · Cited by 11
Decoding CLU (Clusterin): Conquering cancer treatment resistance and immunological barriers
Mamun, M., Zheng, Y., Wang, N., Wang, B., Zhang, Y. X., Pang, J., Shen, D., Liu, H., & Gao, Y. (2024) · International Immunopharmacology · doi:10.1016/j.intimp.2024.112355 · Cited by 10
Novel Targeted Therapies for Prostate Cancer
Macfarlane, R. J., & Chi, K. N. (2010) · Urologic Clinics of North America · doi:10.1016/j.ucl.2009.11.011 · Cited by 10
Gondek, M., Herosimczyk, A., Knysz, P., Ozgo, M., Lepczyński, A., & Szkucik, K. (2020) · Pathogens · doi:10.3390/pathogens9010055 · Cited by 10
Wijerathna, H. M. S. M., Nadarajapillai, K., Udayantha, H. M. V., Kasthuriarachchi, T. D. W., Shanaka, K. A. S. N., Kwon, H., Wan, Q., & Lee, J. (2022) · Fish & Shellfish Immunology · doi:10.1016/j.fsi.2022.04.015 · Cited by 10
Secretion and Immunogenicity of the Meningioma-Associated Antigen TXNDC16
Harz, C., Ludwig, N., Lang, S., Werner, T. V., Galata, V., Backes, C., Schmitt, K., Nickels, R. M., Krause, E., Jung, M., et al. (2014) · The Journal of Immunology · doi:10.4049/jimmunol.1303098 · Cited by 10
Differential expression of genes characterizing myofibre phenotype
Nierobisz, L. S., Sporer, K. R. B., Strasburg, G. M., Reed, K. M., Velleman, S. G., Ashwell, C. M., Felts, J. V., & Mozdziak, P. E. (2011) · Animal Genetics · doi:10.1111/j.1365-2052.2011.02249.x · Cited by 10
Sun, B., Moibi, J. A., Mak, A., Xiao, Z. J., Roa, W., & Moore, R. B. (2009) · The Journal of Urology · doi:10.1016/j.juro.2008.10.148 · Cited by 10
NF-κB-dependent genes induced by proteinuria and identified using DNA microarrays
Takase, O., Marumo, T., Hishikawa, K., Fujita, T., Quigg, R. J., & Hayashi, M. (2008) · Clinical and Experimental Nephrology · doi:10.1007/s10157-008-0038-5 · Cited by 10
Yao, M., Sai, W., Zheng, W., Wang, L., Dong, Z., & Yao, D. (2020) · Current Medicinal Chemistry · doi:10.2174/0929867326666190624161158 · Cited by 10
Padilla-Mendoza, J. R., de Oca, A. C.-M., Rodríguez, M. A., López‐Casamichana, M., Bolaños, J., Granados, L. I. Q., Reyes‐Hernández, O. D., Fragozo-Sandoval, F., Reséndiz‐Albor, A. A., Arellano-Gutiérrez, C. V., et al. (2020) · BioMed Research International · doi:10.1155/2020/5058928 · Cited by 10
Yanni, A. E., Agrogiannis, G. D., Gkekas, C., & Perrea, D. N. (2014) · Lipids in Health and Disease · doi:10.1186/1476-511x-13-70 · Cited by 10
Therapeutic Potential of Clusterin Inhibition in Human Cancer
Martín‐García, D., García‐Aranda, M., & Redondo, M. (2024) · Cells · doi:10.3390/cells13080665 · Cited by 9
Bouaouiche, S., Magadoux, L., Dondaine, L., Reveneau, S., Isambert, N., Bettaı̈eb, A., Jeannin, J., Laurens, V., & Plenchette, S. (2019) · International Journal of Oncology · doi:10.3892/ijo.2019.4708 · Cited by 9
Cytoplasmic Clusterin Suppresses Lung Cancer Metastasis by Inhibiting the ROCK1-ERK Axis
Huang, S., Li, X., Gu, W., Li, X., Zhao, J., Wu, J., Cai, J., Feng, X., & Tao, T. (2022) · Cancers · doi:10.3390/cancers14102463 · Cited by 9
Wang, C., Zeng, Z., Liu, Q., Zhang, R., & Ni, J. (2014) · International Journal of Molecular Sciences · doi:10.3390/ijms151121331 · Cited by 9
Self-citationBrain and plasmatic CLUSTERIN are translational markers of Alzheimer's disease
Tournier, B. B., Ceyzériat, K., Marteyn, A., Amossé, Q., Badina, A. M., Tsartsalis, S., Herrmann, F. R., Zekry, D., & Millet, P. (2024) · Brain Pathology · doi:10.1111/bpa.13281 · Cited by 9
Cichowska, A. W., Wiśniewski, J. Ł., Bromke, M. A., Olejnik, B., & Mogielnicka-Brzozowska, M. (2023) · International Journal of Molecular Sciences · doi:10.3390/ijms241914790 · Cited by 8
Chapter 4 Regulation of Clusterin Activity by Calcium
Pająk, B., & Orzechowski, A. (2009) · Advances in cancer research · doi:10.1016/s0065-230x(09)04004-4 · Cited by 8
Flavored little cigar smoke induces cytotoxicity and apoptosis in airway epithelia
Ghosh, A., Nethery, R. C., Herring, A. H., & Tarran, R. (2017) · Cell Death Discovery · doi:10.1038/cddiscovery.2017.19 · Cited by 9
Schweitzer, M., Mitmaker, B., Obrand, D. I., Sheiner, N., Abraham, C., Dostanic, S., & Chalifour, L. E. (2009) · Canadian Journal of Physiology and Pharmacology · doi:10.1139/y09-085 · Cited by 8
Doxazosin-induced clusterin expression and apoptosis in prostate cancer cells
Youm, Y., Yang, H., Yoon, Y., Kim, D.-Y., Lee, C., & Yoo, T. K. (2007) · Urologic Oncology Seminars and Original Investigations · doi:10.1016/j.urolonc.2007.02.010 · Cited by 8
Ferrearin C induces apoptosis via heme oxygenase-1 (HO-1) induction in neuroblastoma
Hayama, T., Tabata, K., Uchiyama, T., Fujimoto, Y., & Suzuki, T. (2011) · Journal of Natural Medicines · doi:10.1007/s11418-011-0514-1 · Cited by 8
[Hypomania/mania induced by cessation of antidepressant drugs].
Kora, K., & Kaplan, P. (2008) · PubMed · Cited by 8
Wang, Y., Jia, Y., Yan, L., Fu, J., Hao, M., Chen, W. L., Yao, B., Zhao, P., & Zhou, Z. (2017) · Chemico-Biological Interactions · doi:10.1016/j.cbi.2017.08.002 · Cited by 8
Octreotide induces apoptosis in the oxyntic mucosa
Erlandsen, S. E., Fykse, V., Waldum, H. L., & Sandvik, A. K. (2007) · Molecular and Cellular Endocrinology · doi:10.1016/j.mce.2006.12.031 · Cited by 8
Emerging apoptosis agonists for bladder cancer
Protzel, C., & Hakenberg, O. W. (2009) · Expert Opinion on Emerging Drugs · doi:10.1517/14728210903251708 · Cited by 7
Narahara, S., Watanabe, T., Nagaoka, K., Fujimoto, N., Furuta, Y., Tanaka, K., Tokunaga, T., Kawasaki, T., Yoshimaru, Y., Setoyama, H., et al. (2021) · Hepatology Communications · doi:10.1002/hep4.1872 · Cited by 7
Shin, Y. J., Jo, E. H., Oh, Y., Kim, D. S., Hyun, S., Yu, A.-R., Hong, H. K., & Cho, Y. B. (2023) · Cancers · doi:10.3390/cancers15235531 · Cited by 7
From Humans to Experimental Models: The Cytoprotective Role of Clusterin in the Kidney
Alnasser, Q. G. H. A. (2014) · Medical & Surgical Urology · doi:10.4172/2168-9857.1000134 · Cited by 7
Kumar, V. S. S., Pretorius, E., & Rajanikant, G. K. (2018) · Cellular and Molecular Neurobiology · doi:10.1007/s10571-018-0605-6 · Cited by 7
CLU blocks HDACI-mediated killing of neuroblastoma
Subramanian, C., Jarzembowski, J. A., Halsey, S. M., Kuick, R. D., Opipari, A. W., Castle, V. P., & Kwok, R. P. S. (2010) · Tumor Biology · doi:10.1007/s13277-010-0120-y · Cited by 7
Shim, J.-H., Choi, C.-S., Lee, E.-C., Kim, M.-Y., & Chun, Y. (2009) · Biomolecules & Therapeutics · doi:10.4062/biomolther.2009.17.1.25 · Cited by 7
The Role of Genetics in Alzheimer's Disease and Parkinson's Disease
Porter, T., Gozt, A., Mastaglia, F. L., & Laws, S. M. (2019) · Wiley eBooks · doi:10.1002/9781119356752.ch15 · Cited by 6
Zhang, C., Yi, W., Shao, Z., Yao, B., Tian, G., Li, F., Du, X., Hu, Y., Guo, Y., Wu, T., et al. (2025) · Allergy · doi:10.1111/all.70021 · Cited by 6
Das, L. N., Shekhar, S., Chandrani, P., & Varma, A. K. (2021) · Journal of Biomolecular Structure and Dynamics · doi:10.1080/07391102.2021.2007791 · Cited by 6
Rist, M., Kaku, M., & Coffin, J. M. (2025) · PLoS Pathogens · doi:10.1371/journal.ppat.1013087 · Cited by 6
Hsu, W.-T., Kobuchi, S., Chien, T.-C. R., Chen, I., Hamada, S., Tsujimoto, M., Tsai, I., Wong, Y.-S., Tung, K.-H., & He, Y.-Z. (2025) · Biology Direct · doi:10.1186/s13062-025-00664-5 · Cited by 7
Zhang, Q., Teow, J. Y., Kerishnan, J. P., Halim, A. A. A., & Chen, Y. (2023) · Biomedicines · doi:10.3390/biomedicines11051458 · Cited by 7
Gómez, J. A., Sun, W., Gama, V., Hájková, D., Yoshida, T., Wu, Z., Miyagi, M., Pink, J. J., Jackson, M. W., Danielpour, D., et al. (2009) · Cancer Biology & Therapy · doi:10.4161/cbt.8.18.9323 · Cited by 6
RETRACTED: Horizon scanning for novel therapeutics for the treatment of prostate cancer
Bianchini, D., Zivi, A., Sandhu, S. K., & Bono, J. S. D. (2010) · Expert Opinion on Investigational Drugs · doi:10.1517/13543784.2010.514261 · Cited by 6
RetractedDu, J., Liu, L., Yu, B., Hao, F., Liu, G., Jing, H., & Xu, H. (2018) · PubMed Central · Cited by 6
Transcriptional analysis of cleft palate in TGFβ3 mutant mice
Liu, J., Chanumolu, S. K., White, K. M., Albahrani, M., Otu, H. H., & Nawshad, A. (2020) · Scientific Reports · doi:10.1038/s41598-020-71636-0 · Cited by 6
Rajasekaran, S., Tangavel, C., Raja, S. D. C., Raveendran, M., Nayagam, S. M., Anand, K. S. S. V., Prasad, S. A., & Mugesh, K. R. (2021) · European Spine Journal · doi:10.1007/s00586-021-06826-z · Cited by 6
Antisense therapies for cancer
MacLeod, A. R. (2013) · Drug Discovery Today Therapeutic Strategies · doi:10.1016/j.ddstr.2013.04.002 · Cited by 6
Association of clusterin with the BRI2-derived amyloid molecules ABri and ADan
Rostagno, A. A., Calero, M., Holton, J. L., Révész, T., Lashley, T., & Ghiso, J. A. (2021) · Neurobiology of Disease · doi:10.1016/j.nbd.2021.105452 · Cited by 6
Andries, V., Vandepoele, K., & van, F. (2012) · InTech eBooks · doi:10.5772/28470 · Cited by 6
Germ cell-specific apoptosis by extracellular clusterin in cryptorchid dog testes
Jhun, H., Park, H.-J., Lee, R., Song, H., Hur, T., Lee, S., Park, J.-K., & Lee, W.-Y. (2018) · Animal Reproduction Science · doi:10.1016/j.anireprosci.2018.04.064 · Cited by 6
Fink, D., Fazli, L., Aronow, B. J., Gleave, M. E., & Ong, C. J. (2006) · The Prostate · doi:10.1002/pros.20461 · Cited by 6
Inamdar, T. V., Krannich, F., Hesselbarth, N., Verma, A., Vauti, T., Jasaszwili, M., Kassem, G. E., Hillmer, J., Kaune, T., Boettcher, M., et al. (2025) · Gut · doi:10.1136/gutjnl-2025-335947 · Cited by 5
Novel Targeted Agents on the Horizon for Castration-Resistant Prostate Cancer
Koupparis, A. J., Casey, R. G., Robinson, M., & Gleave, M. E. (2010) · Future Oncology · doi:10.2217/fon.10.145 · Cited by 5
Li, Y., Wang, X., Chen, Y., Tan, Q., Liu, X.-B., & Tan, C. (2023) · Anti-Cancer Drugs · doi:10.1097/cad.0000000000001561 · Cited by 5
New targets and non-cytotoxics in ovarian cancer
Eisenhauer, E. A. (2006) · Annals of Oncology · doi:10.1093/annonc/mdl268 · Cited by 5
Nishikawa, M., Miyake, H., Gleave, M. E., & Fujisawa, M. (2016) · Targeted Oncology · doi:10.1007/s11523-016-0448-3 · Cited by 5
Iyer, S. V., Park, M.-J., Moons, D. S., Kwan, R., Liao, J., Liu, L., & Omary, M. B. (2016) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2016.12.039 · Cited by 5
Distinct Ultradian Rhythms in Plasma Clusterin Concentrations in Lean and Obese Korean Subjects
Choi, J. H., Jeong, E., Youn, B. S., & Kim, M. (2018) · Endocrinology and Metabolism · doi:10.3803/enm.2018.33.2.245 · Cited by 5
Suzuki, T. (2020) · YAKUGAKU ZASSHI · doi:10.1248/yakushi.19-00178 · Cited by 5
Molecular Chaperone Inhibitors
Moses, M. A., Zuehlke, A. D., & Neckers, L. (2018) · Springer eBooks · doi:10.1007/978-3-319-69042-1_2 · Cited by 5
Omwancha, J., Anway, M. D., & Brown, T. R. (2008) · The Prostate · doi:10.1002/pros.20866 · Cited by 5
Molecular and Genetic Profiling of Prostate Cancer: Implications for Future Therapy
Saia, G., Zhang, M., Depalo, V., Lautenschlaeger, T., & Chakravarti, A. (2007) · Current Cancer Therapy Reviews · doi:10.2174/157339407780126647 · Cited by 5
Sex differences in progressive multiple sclerosis brain gene expression in oligodendrocytes and OPCs
LaBarre, B. A., King, D., Ploumakis, A., Pinzon, A. M., Guttmann, C. R. G., Patsopoulos, N., & Chitnis, T. (2025) · BMC Medical Genomics · doi:10.1186/s12920-025-02294-2 · Cited by 4
Muñoz-Baquero, M., Lorenzo-Rebenaque, L., García‐Domínguez, X., Valdés‐Hernández, J., García‐Párraga, D., Marín, C., García‐Vázquez, F. A., & Marco‐Jiménez, F. (2024) · Animals · doi:10.3390/ani14091281 · Cited by 4
Xiong, L., Sun, Y., Niu, R., Xue, L., Chen, L., Huangfu, L., Li, J., Wang, Y., Liu, X., Wang, W., et al. (2024) · Research · doi:10.34133/research.0536 · Cited by 4
Clusterin can mediate apoptosis-induced molecular mechanisms in immune thrombocytopenia
Stein, T., Bitsina, C., Seiler, M., Schmugge, M., & Franzoso, F. D. (2024) · Blood Vessels Thrombosis & Hemostasis · doi:10.1016/j.bvth.2024.100012 · Cited by 4
Amada, K., Hijiya, N., Ikarimoto, S., Yanagihara, K., Hanada, T., Hidano, S., Kurogi, S., Tsukamoto, Y., Nakada, C., Kinoshita, K., et al. (2023) · Cancer Science · doi:10.1111/cas.15735 · Cited by 5
Sciatic Nerve Ligation Downregulates Mitochondrial Clusterin in the Rat Prefrontal Cortex
Rodríguez‐Rivera, C., Girón, R., Sánchez-Robles, E., González‐Martín, C., Goicoechea, C., & Alguacil, L. F. (2020) · Neuroscience · doi:10.1016/j.neuroscience.2020.08.010 · Cited by 4
Anti-colorectal cancer effect and mechanism of a polysaccharide from Ruditapes philippinarum
Zhang, X., Liu, M., Zhang, X., Du, Z., Yuxi, W., & Li, F. (2025) · European Journal of Nutrition · doi:10.1007/s00394-025-03794-8 · Cited by 3
Noncoding-RNA-Based Therapeutics with an Emphasis on Prostatic Carcinoma—Progress and Challenges
Nava, V. E., Perera, P., Kumar, N., & Jain, M. (2022) · Vaccines · doi:10.3390/vaccines10020276 · Cited by 3
Cell Biology of Prostate Cancer and Molecular Targets
Gleave, M. E., Cox, M., & Wang, Y. Z. (2010) · Springer eBooks · doi:10.1007/978-1-60327-829-4_1 · Cited by 3
Apoptosis in the Development and Treatment of Laryngeal Cancer: Role of p53, Bcl-2 and Clusterin
Redondo, M., Fúnez, R., & Esteban, F. (2009) · Springer eBooks · doi:10.1007/978-1-4020-9597-9_10 · Cited by 3
Radicicol induces intracellular accumulation of glycan-deficient clusterin variant
Choi, I., Lee, Y., Park, J., Song, Y., Chang, E., & Kang, S. (2015) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2015.02.005 · Cited by 3
Zhang, X., Liu, C., Li, K., Wang, K., Zhang, Q., & Cui, Y. (2019) · Medicine · doi:10.1097/md.0000000000014254 · Cited by 3
Clusterin levels in undernourished SH-SY5Y cells
Rodríguez‐Rivera, C., Pérez‐Carrión, M. D., Olavarría, L. C., Alguacil, L. F., Polanco, M. J., & González‐Martín, C. (2021) · Food & Nutrition Research · doi:10.29219/fnr.v65.5709 · Cited by 2
Martens, G. A., Geßner, C., Osterhof, C., Hankeln, T., & Burmester, T. (2022) · BMC Neuroscience · doi:10.1186/s12868-022-00744-6 · Cited by 2
Calabrò, M., Lui, M., Mazzon, E., & D’Angiolini, S. (2024) · International Journal of Molecular Sciences · doi:10.3390/ijms25063374 · Cited by 2
Razia, R., Majeed, F., Amin, R., Ayub, M. N., Mukhtar, S. M., Mahmood, K., Shabbir, H., Bashir, S., & Baig, D. N. (2024) · Heliyon · doi:10.1016/j.heliyon.2024.e34912 · Cited by 2
Tabuchi, Y., Kariya, A., Yunoki, T., & Kondo, T. (2012) · Thermal Medicine · doi:10.3191/thermalmed.28.29 · Cited by 2
The Tumor Suppressor von Hippel-Lindau Gene Product and Metastasis
Mukhopadhyay, D. (2006) · American Journal Of Pathology · doi:10.2353/ajpath.2006.051202 · Cited by 2
Rodríguez‐Rivera, C., Pérez‐Ortiz, J. M., Pook, E., Conjaerts, N., Alguacil, L. F., & González‐Martín, C. (2021) · Food and Chemical Toxicology · doi:10.1016/j.fct.2021.112186 · Cited by 2
Dabbs, R. A., Wyatt, A. R., Yerbury, J. J., Ecroyd, H. W., & Wilson, M. R. (2010) · Topics in current chemistry · doi:10.1007/128_2010_85 · Cited by 2
Zinc-binding proteins in stallion seminal plasma as potential sperm function regulators
Mogielnicka-Brzozowska, M., Piatkowska, E. M., Fraser, L., Cichowska, A. W., Załęcki, M., Kraziński, B. E., Słowińska, M., & Kordan, W. (2022) · Annals of Animal Science · doi:10.2478/aoas-2022-0015 · Cited by 2
Cheng, J., Liu, M., Qiao, Y., Zhu, Z., Zhang, G., & Li, P. (2026) · Biology of Reproduction · doi:10.1093/biolre/ioag124 · Cited by 1
Metadata
- Authors
- Zhang, H., Kim, J. K., Edwards, C. A., Xu, Z., Taichman, R., & Wang, C.-Y.
- Affiliations
- University of Michigan (US)
- Corresponding author
- Wang, Cun-Yu
- Venue
- Nature Cell Biology
- Published
- 2005-08-21
- Volume
- 7
- Issue
- 9
- Pages
- 909-915
- ISSN
- 1465-7392 (ISSN-L)
- 1476-4679
- OpenAlex
- W2093107372
- Cited by
- 453
- References
- 27
- Citations by year
- 2026: 5 · 2025: 7 · 2024: 13 · 2023: 18 · 2022: 19 · 2021: 22 · 2020: 21 · 2019: 16 · 2018: 19 · 2017: 16 · 2016: 18 · 2015: 20 · 2014: 24 · 2013: 27 · 2012: 31
- FWCI
- 10.73
- Type
- journal article
- Language
- en
- Open access
- closed
- Licence
- www.springer.com/tdm (tdm)
- Locations
- Nature Cell Biology (publishedVersion)
- PubMed (publishedVersion)
- Funders
- National Institutes of Health
- Army Research Office
- Topics
- Health Sciences › Medicine › Oncology › Clusterin in disease pathology
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Cell death mechanisms and regulation
- Life Sciences › Immunology and Microbiology › Immunology › Biomarkers in Disease Mechanisms
- Keywords
- clusterin, apoptosis inhibition, Bax activation, Bax oligomerization, cytochrome c release, caspase activation, c-Myc, oncogenic transformation, tumor progression, chemosensitization, prostate cancer, breast cancer, squamous cell carcinoma, mitochondrial apoptosis
- MeSH terms
- Animals, Antineoplastic Agents, Cell Transformation, Neoplastic, Glycoproteins, Humans, Mitochondria, Neoplasms, Protein Conformation, Proto-Oncogene Proteins c-myc, Apoptosis, Molecular Chaperones, Drug Resistance, Neoplasm, Proto-Oncogene Proteins c-bcl-2, Caspases, Cytochromes c, Cell Line, Tumor, bcl-2-Associated X Protein, Clusterin, Rats
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review